Azure Synthetics Azure Synthetics Research peptides, clearly documented.
SLU-PP-332

Metabolic research

SLU-PP-332

Lyophilized metabolic research compound

SLU-PP-332 is an ERR-pathway research compound studied in exercise-mimetic and metabolic adaptation literature.

Price range: 46.99 $ through 199.99 $
98.2%-99.0% Lyophilized powder 10 mg
Available documentation

Support can confirm any currently available COAs or batch documentation for this product.

Request available documents

For laboratory research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure, mitigate, or prevent disease.

Storage

Keep sealed, cold, dry, and protected from heat swings. Confirm product-specific storage on arrival.

Shipping notes

Packed for transit stability with order support available for warm-weather routes.

Batch reference

Batch-linked certificate support is available through the documentation desk.

शोध संदर्भ

SLU-PP-332 शोध प्रोफ़ाइल

SLU-PP-332 is a small-molecule research compound associated with estrogen-related receptor signaling rather than a peptide hormone pathway. Preclinical studies use it to investigate oxidative metabolism, mitochondrial gene programs, skeletal-muscle adaptation, energy expenditure, and exercise-mimetic phenotypes. The ERR family helps regulate transcriptional networks involved in cellular energy use, so studies often measure gene expression, mitochondrial markers, endurance-related endpoints, and tissue-specific metabolic changes. This compound is best suited to mechanistic cell and animal research that specifically requires an ERR-pathway agonist. The published evidence is preclinical, and experimental findings do not establish human safety, effectiveness, or an appropriate personal-use context.

Molecular class

Synthetic estrogen-related receptor agonist

Sequence / composition

A synthetic small molecule, not a peptide; its chemical scaffold is used to probe ERR transcriptional programs.

Research design note

Research should separate direct ERR engagement from downstream mitochondrial and metabolic transcriptional responses.

प्रस्तावित तंत्र

A synthetic agonist reported to activate estrogen-related receptors, especially ERRalpha, ERRbeta, and ERRgamma. ERR activation regulates transcriptional programs involved in mitochondrial biogenesis, oxidative phosphorylation, fatty-acid oxidation, and oxidative muscle-fiber identity.

अध्ययनों में बताए गए प्रभाव

  • Cell studies reported induction of ERR-regulated oxidative and mitochondrial gene programs.
  • Mouse studies reported increased oxidative muscle characteristics, endurance, energy expenditure, and resistance to diet-related metabolic changes.
  • The compound is a small molecule rather than a peptide, and no established human efficacy or safety profile exists.

सामान्य शोध एंडपॉइंट

ERR transcriptional activity, mitochondrial genes, oxygen consumption, fatty-acid oxidation, muscle-fiber type, exercise capacity, energy expenditure, glucose tolerance, and body composition.

साक्ष्य और सीमाएँ

Evidence is limited to mechanistic and animal research. Human effects, pharmacokinetics, and safety remain unestablished.

External reading

Literature for context—not product proof.

Third-party sources describe their own research materials and methods. They do not validate a specific Azure catalog batch.

Support and documentation

Questions about this product?

Where can I find product documentation?

Contact support with the product name and any relevant order or batch reference to request available documents.

How can I compare pack options?

Where multiple pack sizes are available, Azure shows the price per listed vial so you can compare catalog value directly.